{"entity":{"id":"nct07515820","kind":"trial","name":"SHR-3821 in Advanced Colorectal Cancer: an Exploratory Study","aka":[],"tldr":"A phase 2 trial of fruquintinib in colorectal cancer, run by Meng Qiu, not yet recruiting.","summary":"SHR-3821 in Advanced Colorectal Cancer: an Exploratory Study is a phase 2, interventional study registered as NCT07515820 by Meng Qiu, with a registry enrolment figure of 12 participants, started 2026-04-27 and due to reach its primary completion in 2027-07-28. Interventions recorded: SHR-3821 and fruquintinib. Conditions listed: Colorectal Cancer. Primary outcome: Incidence of treatment related adverse event [Safety and Tolerability]; Objective response rate (ORR). Colorectal eligibility wording from the registry: \"Histologically or cytologically confirmed unresectable recurrent or metastatic colorectal cancer\". No results are recorded here; the registry entry is the source.","status":"planned","asOf":"2026-09-24","links":[{"label":"ClinicalTrials.gov NCT07515820","url":"https://clinicaltrials.gov/study/NCT07515820"}],"tags":["ctgov-ingest","colorectal-deep-dive"],"related":[],"cancers":["rectal-cancer","colon-cancer"],"sections":[],"technologies":["antiangiogenic","kinase-inhibitors"],"targets":[],"drugs":["fruquintinib"],"companies":["hengrui"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT07515820","phase":"2","setting":"SHR-3821 in Advanced Colorectal Cancer: an Exploratory Study","sponsor":"Meng Qiu","enrolled":12,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct07515820/","neighbours":{"cancer":[{"id":"colon-cancer","kind":"cancer","name":"Colon cancer (adenocarcinoma of the colon)","route":"/cancers/colon-cancer/"},{"id":"rectal-cancer","kind":"cancer","name":"Rectal cancer","route":"/cancers/rectal-cancer/"}],"technology":[{"id":"antiangiogenic","kind":"technology","name":"Anti-angiogenic therapy","route":"/technologies/antiangiogenic/"},{"id":"kinase-inhibitors","kind":"technology","name":"Small-molecule kinase inhibitors","route":"/technologies/kinase-inhibitors/"}],"drug":[{"id":"fruquintinib","kind":"drug","name":"Fruquintinib","route":"/drugs/fruquintinib/"}],"company":[{"id":"hengrui","kind":"company","name":"Jiangsu Hengrui Pharmaceuticals","route":"/companies/hengrui/"}],"term":[{"id":"colorectal-trials-open-today","kind":"term","name":"Colorectal cancer trials open today (registry snapshot)","route":"/terms/colorectal-trials-open-today/"}]}}